Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Olanzapine is the generic name for Zyprexa, an atypical antipsychotic used to treat schizophrenia and bipolar disorder, and sometimes prescribed alongside other medications for treatment-resistant depression. It comes in several forms, including standard tablets, orally disintegrating tablets (Zyprexa Zydis), and an injectable version, and dosing varies widely depending on the condition being treated. Generic olanzapine contains the same active ingredient as the brand-name version, though there are important differences in cost, available formulations, and side effect considerations to review below.
Because olanzapine can cause weight gain, drowsiness, metabolic changes, and movement-related side effects, understanding whether your symptoms stem from your condition or your medication matters. A free, instant, online symptom check can help you organize what you are experiencing and identify which next steps or specialists to discuss with your doctor.
Last reviewed for medical accuracy: 09/24/2026
Zyprexa is the brand name for the antipsychotic medication olanzapine. When Zyprexa lost patent protection, generic versions became available. Understanding the difference between brand-name Zyprexa and its generic, olanzapine, can help you make informed choices about your treatment.
A generic drug is a medication that:
Generic drugs are typically less expensive because manufacturers do not repeat the costly clinical trials already performed by the brand-name company.
Olanzapine works by adjusting the activity of certain neurotransmitters in the brain—mainly dopamine and serotonin—to help manage symptoms of psychosis, mood swings, and other mental health conditions.
Olanzapine (Zyprexa generic) is commonly prescribed for:
Your doctor will decide if olanzapine is right for you based on your symptoms, medical history, and treatment goals.
Dosage varies depending on the condition being treated, your response to the medication, and other health factors:
Never adjust your dose or stop taking olanzapine without talking to your doctor first. Abrupt changes can lead to withdrawal symptoms or a return of underlying symptoms.
Like all medications, olanzapine can cause side effects. Many people tolerate generic olanzapine well, but watch for:
These side effects often lessen after a few weeks. If they persist or become bothersome, contact your healthcare provider.
Although uncommon, some side effects require immediate medical attention:
If you experience any of these, seek medical care right away.
| Brand-Name Zyprexa | Generic Olanzapine |
|---|---|
| Higher price point | Usually much lower |
| Possible manufacturer coupons | Rarely needed |
| Brand loyalty value | Equally effective |
Your actual cost will depend on pharmacy, insurance, and available discounts.
Yes. Zyprexa is the brand name; olanzapine is the generic name. Both contain the same active ingredient.
In most cases, no. The generic delivers the same dosage and effect, but it’s wise to watch for any small changes in how you feel and report them to your doctor.
Yes. Generic antipsychotics approved by agencies like the FDA must meet rigorous standards for safety, quality, and efficacy.
Some people notice improvement in a few days; for others, it may take several weeks. Patience and open communication with your healthcare provider are key.
If you ever feel your symptoms are worsening, or you notice serious side effects, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help you decide if you need medical attention. Free, online symptom check, using the doctor approved Ubie Symptom Checker
Always prioritize your safety. If you experience life-threatening or serious symptoms—such as chest pain, severe allergic reactions, or thoughts of harming yourself—seek emergency care or call emergency services immediately.
Understanding the Zyprexa generic (olanzapine) can empower you to make cost-effective, safe choices in your treatment plan. Generics offer the same quality and effectiveness as brand-name medications at a lower price, helping you stick with your therapy without undue financial strain.
Remember to:
Your health matters. Speak to a doctor about anything that could be life-threatening or serious.
(References)
* Klinger G, Stahl B, Fusar-Poli P, Merlob P. Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev. 2013 Mar-Apr;10(3):308-17. PMID: 23724438.
* Italiano D, Bruno A, Santoro V, Lanza G, Muscatello MR, Zoccali R, Spina E. Generic Olanzapine Substitution in Patients With Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching. Ther Drug Monit. 2015 Dec;37(6):827-30. doi: 10.1097/FTD.0000000000000211. PMID: 25830930.
* Mahmood S, Hussain S, Ur Rehman T, Barbui C, Kurdi AB, Godman B. Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future. Curr Med Res Opin. 2019 Jan;35(1):51-61. doi: 10.1080/03007995.2018.1513834. Epub 2018 Sep 20. PMID: 30122062.
* Mishuk AU, Chen L, Li C, Huo N, Hansen RA, Harris I, Kiptanui Z, Qian J. Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study. Curr Med Res Opin. 2021 Apr;37(4):655-664. doi: 10.1080/03007995.2021.1882413. Epub 2021 Feb 18. PMID: 33507825.
* Etteldorf A, Rotolo S, Sedhom R, Vogel RI, Blaes A, Dusetzina SB, Virnig B, Gupta A. Finding the Lowest-Cost Pharmacy for Cancer Supportive Care Medications: Not So Easy. JCO Oncol Pract. 2022 Aug;18(8):e1342-e1349. doi: 10.1200/OP.22.00051. Epub 2022 May 27. PMID: 35623024; PMCID: PMC9377721.
* Zhang C, Ding Y, Wu Z, Wang J, Wu X, Xie W. Does China's competitive generic substitution policy deliver equivalent clinical outcomes? A pilot study with two generic formulations of olanzepine. Front Pharmacol. 2023;14:1097600. doi: 10.3389/fphar.2023.1097600. Epub 2023 Feb 22. PMID: 36909190; PMCID: PMC9999380.
* Sodhi S, Singh H, Sharma AK, Mina S, Gupta S, Vadanere NP. Prescribing Patterns and Adverse Reactions of Antipsychotics in a North Indian Psychiatry Outpatient Department. Cureus. 2025 Nov;17(11):e96281. doi: 10.7759/cureus.96281. Epub 2025 Nov 7. PMID: 41362505; PMCID: PMC12681964.
* Dong F, Wang Z, Li C, Li X, Zhu D, Li J, Wang Z, Gong J, Zhou J, Liu H, Zhang Y, Zhang X, Chen X, Yu M, Tan X, Qian M, Luo Y, Guo WJ, Xie S, Huang J, Zhao J, Wan J, Shan Y, Li N, Wang J, Ju Y, Wang J, Bian Q, Wang G. Intramuscular Generic Injection (QLG2072) versus Haloperidol in Chinese Patients with Acute Agitation: A Phase 3 Multicenter, Randomized, Double-Blind, Active-Controlled Trial. Drug Des Devel Ther. 2026;20:561494. doi: 10.2147/DDDT.S561494. Epub 2026 Feb 25. PMID: 41778148; PMCID: PMC12951296.
* Du P, Chen X, Xu Y, Zhou Y, Gao H. Drug-Associated Ketoacidosis: A Comprehensive Disproportionality Analysis Based on the FAERS Database. Diabetes Obes Metab. 2026 Jul;28(7):5893-5906. doi: 10.1111/dom.70790. Epub 2026 Apr 20. PMID: 42010884.
* 2026 Jan. PMID: 42118876.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.